ConductScience.org, home
Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma
API referenceFor AI assistants

Trial · NCT03267940

Adverse events1,740

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 1,740

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherAnaemiaBlood and lymphatic system disordersRun-in Portion: PEGCISGEM49
otherAnaemiaBlood and lymphatic system disordersRun-in Portion: PEGCISGEMATEZO69
otherAnaemiaBlood and lymphatic system disordersExpansion Portion: PEGCISGEM1224
otherAnaemiaBlood and lymphatic system disordersExpansion Portion: PEGCISGEMATEZO Twice Weekly1522
otherAnaemiaBlood and lymphatic system disordersExpansion Portion: PEGCISGEMATEZO Once Weekly/Twice Weekly311
otherAnaemiaBlood and lymphatic system disordersExpansion Portion: CISGEM810
otherHaemorrhagic anaemiaBlood and lymphatic system disordersRun-in Portion: PEGCISGEM09
otherHaemorrhagic anaemiaBlood and lymphatic system disordersRun-in Portion: PEGCISGEMATEZO09
otherHaemorrhagic anaemiaBlood and lymphatic system disordersExpansion Portion: PEGCISGEM124
otherHaemorrhagic anaemiaBlood and lymphatic system disordersExpansion Portion: PEGCISGEMATEZO Twice Weekly022
otherHaemorrhagic anaemiaBlood and lymphatic system disordersExpansion Portion: PEGCISGEMATEZO Once Weekly/Twice Weekly011
otherHaemorrhagic anaemiaBlood and lymphatic system disordersExpansion Portion: CISGEM010
otherLeukocytosisBlood and lymphatic system disordersRun-in Portion: PEGCISGEM19
otherLeukocytosisBlood and lymphatic system disordersRun-in Portion: PEGCISGEMATEZO09
otherLeukocytosisBlood and lymphatic system disordersExpansion Portion: PEGCISGEM124
otherLeukocytosisBlood and lymphatic system disordersExpansion Portion: PEGCISGEMATEZO Twice Weekly022
otherLeukocytosisBlood and lymphatic system disordersExpansion Portion: PEGCISGEMATEZO Once Weekly/Twice Weekly011
otherLeukocytosisBlood and lymphatic system disordersExpansion Portion: CISGEM010
otherLeukopeniaBlood and lymphatic system disordersRun-in Portion: PEGCISGEM29
otherLeukopeniaBlood and lymphatic system disordersRun-in Portion: PEGCISGEMATEZO19

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03267940/events

API referenceFor AI assistants